84 related articles for article (PubMed ID: 8158842)
21. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
[TBL] [Abstract][Full Text] [Related]
22. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
Kuriyama K
Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
[TBL] [Abstract][Full Text] [Related]
24. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
25. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486
[TBL] [Abstract][Full Text] [Related]
26. [Current status of complete remission rate of acute leukemia in Shanghai].
Shanghai Leukemia Cooperative Group Shanghai 200040 China
Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):17-9. PubMed ID: 11876954
[TBL] [Abstract][Full Text] [Related]
27. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
[TBL] [Abstract][Full Text] [Related]
28. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
29. Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization.
Heesch S; Neumann M; Schwartz S; Bartram I; Schlee C; Burmeister T; Hänel M; Ganser A; Heuser M; Wendtner CM; Berdel WE; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Ann Hematol; 2013 Jun; 92(6):747-58. PubMed ID: 23412561
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia.
Campana D; Hansen-Hagge TE; Matutes E; Coustan-Smith E; Yokota S; Shetty V; Bartram CR; Janossy G
Leukemia; 1990 Sep; 4(9):620-4. PubMed ID: 2395382
[TBL] [Abstract][Full Text] [Related]
31. Quantitative cytology in leukemia research.
Barlogie B; Maddox AM; Johnston DA; Raber MN; Drewinko B; Keating MJ; Freireich EJ
Blood Cells; 1983; 9(1):35-55. PubMed ID: 6344934
[TBL] [Abstract][Full Text] [Related]
32. Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database.
Qasrawi A; Gomes V; Chacko CA; Mansour A; Kesler M; Arora R; Wei S; Ramlal R; Munker R
Leuk Res; 2020 Feb; 89():106301. PubMed ID: 31982153
[TBL] [Abstract][Full Text] [Related]
33. Myeloperoxidase mRNA detection for lineage determination of leukemic blasts: retrospective analysis.
Crisan D; Anstett MJ
Leukemia; 1995 Jul; 9(7):1264-75. PubMed ID: 7630202
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and cytological differences in adult acute lymphatic and acute undifferentiated leukemia].
Abbrederis K; Schmalzl F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):844-51. PubMed ID: 64425
[TBL] [Abstract][Full Text] [Related]
35. Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia.
Patel SH; Vasu S; Guo L; Lemaster O; Byrd JC; Walker A
J Natl Compr Canc Netw; 2020 Jan; 18(1):6-10. PubMed ID: 31910380
[TBL] [Abstract][Full Text] [Related]
36. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
[TBL] [Abstract][Full Text] [Related]
37. [Hepatitic complications and transfusional support in the remission-induction treatment of acute myeloid leukemia. Clinical study of l22 cases].
Orlandi E; Alessandrino EP; Pagnucco G; Bernasconi C
Riv Emoter Immunoematol; 1985; 32(1):41-9. PubMed ID: 3866290
[No Abstract] [Full Text] [Related]
38. Case report: Venetoclax plus Azacitidine in treatment of acute undifferentiated leukemia.
Cui Y; Mi R; Chen L; Wang L; Li D; Wei X
Hematology; 2024 Dec; 29(1):2293494. PubMed ID: 38095304
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of acute "undifferentiated" leukemia of childhood: ultrastructural, immunophenotypic, and karyotypic analyses.
Stork L; Wilson H; Mierau G; Hays T; Morse H; Jamieson B; Barczuk L; Berry R; Odom L
Am J Pediatr Hematol Oncol; 1990; 12(1):34-44. PubMed ID: 2309978
[TBL] [Abstract][Full Text] [Related]
40. Conversion of acute undifferentiated leukemia phenotypes: analysis of clonal development.
Raghavachar A; Bartram CR; Gaedicke G; Binder T; Heil G; Carbonell F; Kubanek B; Kleihauer E
Leuk Res; 1986; 10(11):1293-9. PubMed ID: 2948079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
